Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PIM Kinases in Multiple Myeloma.
Wu J, Chu E, Kang Y. Wu J, et al. Among authors: chu e. Cancers (Basel). 2021 Aug 26;13(17):4304. doi: 10.3390/cancers13174304. Cancers (Basel). 2021. PMID: 34503111 Free PMC article. Review.
Anaplastic Multiple Myeloma: Case Series and Literature Review.
Wu J, Chu E, Chase CC, Choi T, Gasparetto C, Young K, Kang Y. Wu J, et al. Among authors: chu e. Asploro J Biomed Clin Case Rep. 2022 Jan-Apr;5(1):1-11. doi: 10.36502/2022/asjbccr.6255. Epub 2022 Jan 15. Asploro J Biomed Clin Case Rep. 2022. PMID: 35224465 Free PMC article.
A post-injury immune challenge with lipopolysaccharide following adult traumatic brain injury alters neuroinflammation and the gut microbiome acutely, but has little effect on chronic outcomes.
Rewell SSJ, Shad A, Chen L, Macowan M, Chu E, Gandasasmita N, Casillas-Espinosa PM, Li J, O'Brien TJ, Semple BD. Rewell SSJ, et al. Among authors: chu e. Exp Neurol. 2025 Jan 20;386:115150. doi: 10.1016/j.expneurol.2025.115150. Online ahead of print. Exp Neurol. 2025. PMID: 39842491
Phase I trial of ATR inhibitor elimusertib with FOLFIRI in advanced or metastatic gastrointestinal malignancies (ETCTN 10406).
Krishnamurthy A, Wang H, Rhee JC, Davar D, Moy RH, Ratner L, Christner SM, Holleran JL, Deppas J, Sclafani C, Schmitz JC, Gore S, Chu E, Bakkenist CJ, Beumer JH, Villaruz LC. Krishnamurthy A, et al. Among authors: chu e. Cancer Chemother Pharmacol. 2025 Jan 22;95(1):27. doi: 10.1007/s00280-024-04745-6. Cancer Chemother Pharmacol. 2025. PMID: 39841295 Clinical Trial.
Jansen metaphyseal chondrodysplasia: analysis of craniofacial manifestations.
Obiezu F, Almpani K, Kim HJ, Zalewski C, Chu E, Jahanmir G, Roszko KL, Boyce A, Farhadi F, Weinstein LS, Gafni RI, Ferreira CR, Jüppner H, Collins MT, Lee JS, Jha S. Obiezu F, et al. Among authors: chu e. JBMR Plus. 2024 Nov 26;9(2):ziae156. doi: 10.1093/jbmrpl/ziae156. eCollection 2025 Feb. JBMR Plus. 2024. PMID: 39830149 Free article.
1,191 results